Although PD1-PDL1 has been proven as targetable molecules within the immune regulatory system, it is well known from non-neoplastic diseases, that there are many more ways the immune system can be shifted towards antigen tolerance or even lymphocyte exhaustion. This evidence concerns the gene PDCD1 and neoplasm.